Tradestie Institutional Equity Comparison Engine

ATYR vs ADPT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ATYR Overall Edge

ATYR Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to aTyr Pharma, Inc. Common Stock (ATYR) driven by superior Growth & Margin, Momentum & Technical while ADPT counters with relative strength in Options & Structure. Fundamentally, ATYR trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ADPT at N/M Forward P/E and -16.2% operating margin (-10.7% YoY). In options structure, ATYR sits in UNCLASSIFIED (36th %ile IV; Dealer Gamma Walls on Pro) against ADPT sits in BREAKOUT (36th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ATYR N/M vs ADPT N/M Fwd P/E
Growth & Margin Winner ATYR
Op Margin 0.0% vs -16.2% ยท YoY +0.0% vs -10.7%
Momentum & Technical Winner ATYR
1Y +558.7% vs +102.5% ยท 52W Pos 62% vs 82%
Options & Structure Winner ADPT
UNCLASSIFIED (36th %ile IV) vs BREAKOUT (36th %ile IV)
ATYR NASDAQ
aTyr Pharma, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$4.96
-5.34% 1D
Market Cap $15.6M
1M Return +2788.76%
1Y Return +558.7%
Forward P/E N/M
Unified AI Score
34.3 / 100 SELL
Tech 50.0 Fund 36.0 Flow 69.0 Mom 50.0
ADPT NASDAQ
Adaptive Biotechnologies Corporation Common Stock
Biological Products, (No Disgnostic Substances)
$28.56
+2.48% 1D
Market Cap $4.7B
1M Return +19.25%
1Y Return +102.55%
Forward P/E N/M
Unified AI Score
43.2 / 100 HOLD
Tech 15.0 Fund 42.0 Flow 68.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ATYR +558.7% ADPT +102.55% Spread: +456.15 pp (ATYR Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ATYR Revenue ADPT Revenue ATYR Op. Margin ADPT Op. Margin Margin Edge
FY2018 N/A $60M N/A -89.4% ADPT
FY2019 $0M $90M -5445.0% -92.1% ADPT
FY2020 $10M $100M -152.2% -155.3% ATYR
FY2021 N/A $150M N/A -135.4% ADPT
FY2022 $10M $190M -446.8% -108.0% ADPT
FY2023 $0M $170M -15557.8% -133.3% ADPT
FY2024 $0M $180M -28899.6% -90.8% ADPT
FY2025 $0M $280M -40856.3% -20.6% ADPT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ATYR (3) vs ADPT (5)
Institutional Metric ATYR ADPT Criterion Row Winner
Market Capitalization Scale $15.6M $4.7B Larger Scale ADPT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% -10.7% Higher Growth ATYR
Operating Margin (TTM) Profitability 0.0% -16.2% Higher Margin ATYR
Net Profit Margin Profitability 0.0% -23.7% Higher Margin ATYR
Return on Equity (ROE) Capital Efficiency -93.7% -36.4% Higher ROE ADPT
52-Week Range Position Momentum 62% ($0โ€“$8) 82% ($12โ€“$32) Stronger Trend ADPT
Beta / 30D Volatility Risk Regime -9.67ฮฒ ยท 13806% Vol 1.73ฮฒ ยท 59% Vol Lower Realized Risk ADPT
Unified Institutional Score Composite Signal 34.3 / 100 (SELL) 43.2 / 100 (HOLD) Higher Composite ADPT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ATYR vs ADPT Buy Guide
ATYR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 36th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ATYR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ADPT BREAKOUT
70d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 36th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ADPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ATYR nor ADPT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.